The global market for Long-acting DPP-4 Inhibitor Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Long-acting dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of drugs used to treat type 2 diabetes. They are characterized by a long half-life and extended duration of action, with some formulations allowing for once-weekly dosing and others even every two weeks.

North American market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Long-acting DPP-4 Inhibitor Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Long-acting DPP-4 Inhibitor Drug in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Long-acting DPP-4 Inhibitor Drug include Merck & Co, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, Haisco Pharmaceutical, Easton Biopharmaceuticals, Baiji Dichang Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Long-acting DPP-4 Inhibitor Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting DPP-4 Inhibitor Drug.

The Long-acting DPP-4 Inhibitor Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting DPP-4 Inhibitor Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-acting DPP-4 Inhibitor Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Long-acting DPP-4 Inhibitor Drug Market Report

Report Metric	Details
Report Name	Long-acting DPP-4 Inhibitor Drug Market
Segment by Type	Weekly Biweekly
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & Co, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, Haisco Pharmaceutical, Easton Biopharmaceuticals, Baiji Dichang Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-acting DPP-4 Inhibitor Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Long-acting DPP-4 Inhibitor Drug Market report?

Ans: The main players in the Long-acting DPP-4 Inhibitor Drug Market are Merck & Co, Takeda Pharmaceutical, Furiex, Beacon Pharma, Kelun Pharmaceutical, Haisco Pharmaceutical, Easton Biopharmaceuticals, Baiji Dichang Pharmaceutical

What are the Application segmentation covered in the Long-acting DPP-4 Inhibitor Drug Market report?

Ans: The Applications covered in the Long-acting DPP-4 Inhibitor Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Long-acting DPP-4 Inhibitor Drug Market report?

Ans: The Types covered in the Long-acting DPP-4 Inhibitor Drug Market report are Weekly, Biweekly

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Weekly

1.2.3 Biweekly

1.3 Market by Application

1.3.1 Global Long-acting DPP-4 Inhibitor Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Long-acting DPP-4 Inhibitor Drug Market Perspective (2020-2031)

2.2 Global Long-acting DPP-4 Inhibitor Drug Growth Trends by Region

2.2.1 Global Long-acting DPP-4 Inhibitor Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Long-acting DPP-4 Inhibitor Drug Historic Market Size by Region (2020-2025)

2.2.3 Long-acting DPP-4 Inhibitor Drug Forecasted Market Size by Region (2026-2031)

2.3 Long-acting DPP-4 Inhibitor Drug Market Dynamics

2.3.1 Long-acting DPP-4 Inhibitor Drug Industry Trends

2.3.2 Long-acting DPP-4 Inhibitor Drug Market Drivers

2.3.3 Long-acting DPP-4 Inhibitor Drug Market Challenges

2.3.4 Long-acting DPP-4 Inhibitor Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long-acting DPP-4 Inhibitor Drug Players by Revenue

3.1.1 Global Top Long-acting DPP-4 Inhibitor Drug Players by Revenue (2020-2025)

3.1.2 Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Players (2020-2025)

3.2 Global Long-acting DPP-4 Inhibitor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Long-acting DPP-4 Inhibitor Drug Revenue

3.4 Global Long-acting DPP-4 Inhibitor Drug Market Concentration Ratio

3.4.1 Global Long-acting DPP-4 Inhibitor Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long-acting DPP-4 Inhibitor Drug Revenue in 2024

3.5 Global Key Players of Long-acting DPP-4 Inhibitor Drug Head office and Area Served

3.6 Global Key Players of Long-acting DPP-4 Inhibitor Drug, Product and Application

3.7 Global Key Players of Long-acting DPP-4 Inhibitor Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Long-acting DPP-4 Inhibitor Drug Breakdown Data by Type

4.1 Global Long-acting DPP-4 Inhibitor Drug Historic Market Size by Type (2020-2025)

4.2 Global Long-acting DPP-4 Inhibitor Drug Forecasted Market Size by Type (2026-2031)

5 Long-acting DPP-4 Inhibitor Drug Breakdown Data by Application

5.1 Global Long-acting DPP-4 Inhibitor Drug Historic Market Size by Application (2020-2025)

5.2 Global Long-acting DPP-4 Inhibitor Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Long-acting DPP-4 Inhibitor Drug Market Size (2020-2031)

6.2 North America Long-acting DPP-4 Inhibitor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025)

6.4 North America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Long-acting DPP-4 Inhibitor Drug Market Size (2020-2031)

7.2 Europe Long-acting DPP-4 Inhibitor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025)

7.4 Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size (2020-2031)

8.2 Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Long-acting DPP-4 Inhibitor Drug Market Size (2020-2031)

9.2 Latin America Long-acting DPP-4 Inhibitor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025)

9.4 Latin America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size (2020-2031)

10.2 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck & Co

11.1.1 Merck & Co Company Details

11.1.2 Merck & Co Business Overview

11.1.3 Merck & Co Long-acting DPP-4 Inhibitor Drug Introduction

11.1.4 Merck & Co Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.1.5 Merck & Co Recent Development

11.2 Takeda Pharmaceutical

11.2.1 Takeda Pharmaceutical Company Details

11.2.2 Takeda Pharmaceutical Business Overview

11.2.3 Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Introduction

11.2.4 Takeda Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.2.5 Takeda Pharmaceutical Recent Development

11.3 Furiex

11.3.1 Furiex Company Details

11.3.2 Furiex Business Overview

11.3.3 Furiex Long-acting DPP-4 Inhibitor Drug Introduction

11.3.4 Furiex Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.3.5 Furiex Recent Development

11.4 Beacon Pharma

11.4.1 Beacon Pharma Company Details

11.4.2 Beacon Pharma Business Overview

11.4.3 Beacon Pharma Long-acting DPP-4 Inhibitor Drug Introduction

11.4.4 Beacon Pharma Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.4.5 Beacon Pharma Recent Development

11.5 Kelun Pharmaceutical

11.5.1 Kelun Pharmaceutical Company Details

11.5.2 Kelun Pharmaceutical Business Overview

11.5.3 Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Introduction

11.5.4 Kelun Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.5.5 Kelun Pharmaceutical Recent Development

11.6 Haisco Pharmaceutical

11.6.1 Haisco Pharmaceutical Company Details

11.6.2 Haisco Pharmaceutical Business Overview

11.6.3 Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Introduction

11.6.4 Haisco Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.6.5 Haisco Pharmaceutical Recent Development

11.7 Easton Biopharmaceuticals

11.7.1 Easton Biopharmaceuticals Company Details

11.7.2 Easton Biopharmaceuticals Business Overview

11.7.3 Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Introduction

11.7.4 Easton Biopharmaceuticals Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.7.5 Easton Biopharmaceuticals Recent Development

11.8 Baiji Dichang Pharmaceutical

11.8.1 Baiji Dichang Pharmaceutical Company Details

11.8.2 Baiji Dichang Pharmaceutical Business Overview

11.8.3 Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Introduction

11.8.4 Baiji Dichang Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

11.8.5 Baiji Dichang Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Takeda Pharmaceutical

Beacon Pharma

Kelun Pharmaceutical

Haisco Pharmaceutical

Easton Biopharmaceuticals

Furiex

Baiji Dichang Pharmaceutical

List of Tables

Table 1. Global Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Weekly

Table 3. Key Players of Biweekly

Table 4. Global Long-acting DPP-4 Inhibitor Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Long-acting DPP-4 Inhibitor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Long-acting DPP-4 Inhibitor Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Long-acting DPP-4 Inhibitor Drug Market Share by Region (2020-2025)

Table 8. Global Long-acting DPP-4 Inhibitor Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Long-acting DPP-4 Inhibitor Drug Market Share by Region (2026-2031)

Table 10. Long-acting DPP-4 Inhibitor Drug Market Trends

Table 11. Long-acting DPP-4 Inhibitor Drug Market Drivers

Table 12. Long-acting DPP-4 Inhibitor Drug Market Challenges

Table 13. Long-acting DPP-4 Inhibitor Drug Market Restraints

Table 14. Global Long-acting DPP-4 Inhibitor Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Long-acting DPP-4 Inhibitor Drug Market Share by Players (2020-2025)

Table 16. Global Top Long-acting DPP-4 Inhibitor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting DPP-4 Inhibitor Drug as of 2024)

Table 17. Ranking of Global Top Long-acting DPP-4 Inhibitor Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Long-acting DPP-4 Inhibitor Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Long-acting DPP-4 Inhibitor Drug, Headquarters and Area Served

Table 20. Global Key Players of Long-acting DPP-4 Inhibitor Drug, Product and Application

Table 21. Global Key Players of Long-acting DPP-4 Inhibitor Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Long-acting DPP-4 Inhibitor Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Long-acting DPP-4 Inhibitor Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Long-acting DPP-4 Inhibitor Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Long-acting DPP-4 Inhibitor Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Long-acting DPP-4 Inhibitor Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Merck & Co Company Details

Table 47. Merck & Co Business Overview

Table 48. Merck & Co Long-acting DPP-4 Inhibitor Drug Product

Table 49. Merck & Co Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 50. Merck & Co Recent Development

Table 51. Takeda Pharmaceutical Company Details

Table 52. Takeda Pharmaceutical Business Overview

Table 53. Takeda Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product

Table 54. Takeda Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 55. Takeda Pharmaceutical Recent Development

Table 56. Furiex Company Details

Table 57. Furiex Business Overview

Table 58. Furiex Long-acting DPP-4 Inhibitor Drug Product

Table 59. Furiex Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 60. Furiex Recent Development

Table 61. Beacon Pharma Company Details

Table 62. Beacon Pharma Business Overview

Table 63. Beacon Pharma Long-acting DPP-4 Inhibitor Drug Product

Table 64. Beacon Pharma Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 65. Beacon Pharma Recent Development

Table 66. Kelun Pharmaceutical Company Details

Table 67. Kelun Pharmaceutical Business Overview

Table 68. Kelun Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product

Table 69. Kelun Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 70. Kelun Pharmaceutical Recent Development

Table 71. Haisco Pharmaceutical Company Details

Table 72. Haisco Pharmaceutical Business Overview

Table 73. Haisco Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product

Table 74. Haisco Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 75. Haisco Pharmaceutical Recent Development

Table 76. Easton Biopharmaceuticals Company Details

Table 77. Easton Biopharmaceuticals Business Overview

Table 78. Easton Biopharmaceuticals Long-acting DPP-4 Inhibitor Drug Product

Table 79. Easton Biopharmaceuticals Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 80. Easton Biopharmaceuticals Recent Development

Table 81. Baiji Dichang Pharmaceutical Company Details

Table 82. Baiji Dichang Pharmaceutical Business Overview

Table 83. Baiji Dichang Pharmaceutical Long-acting DPP-4 Inhibitor Drug Product

Table 84. Baiji Dichang Pharmaceutical Revenue in Long-acting DPP-4 Inhibitor Drug Business (2020-2025) & (US$ Million)

Table 85. Baiji Dichang Pharmaceutical Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Long-acting DPP-4 Inhibitor Drug Picture

Figure 2. Global Long-acting DPP-4 Inhibitor Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Long-acting DPP-4 Inhibitor Drug Market Share by Type: 2024 VS 2031

Figure 4. Weekly Features

Figure 5. Biweekly Features

Figure 6. Global Long-acting DPP-4 Inhibitor Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Long-acting DPP-4 Inhibitor Drug Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Long-acting DPP-4 Inhibitor Drug Report Years Considered

Figure 12. Global Long-acting DPP-4 Inhibitor Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Long-acting DPP-4 Inhibitor Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Long-acting DPP-4 Inhibitor Drug Market Share by Region: 2024 VS 2031

Figure 15. Global Long-acting DPP-4 Inhibitor Drug Market Share by Players in 2024

Figure 16. Global Top Long-acting DPP-4 Inhibitor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting DPP-4 Inhibitor Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Long-acting DPP-4 Inhibitor Drug Revenue in 2024

Figure 18. North America Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Long-acting DPP-4 Inhibitor Drug Market Share by Country (2020-2031)

Figure 20. United States Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Long-acting DPP-4 Inhibitor Drug Market Share by Country (2020-2031)

Figure 24. Germany Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Long-acting DPP-4 Inhibitor Drug Market Share by Region (2020-2031)

Figure 32. China Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Long-acting DPP-4 Inhibitor Drug Market Share by Country (2020-2031)

Figure 40. Mexico Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Long-acting DPP-4 Inhibitor Drug Market Share by Country (2020-2031)

Figure 44. Turkey Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Long-acting DPP-4 Inhibitor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck & Co Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 49. Furiex Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 50. Beacon Pharma Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 51. Kelun Pharmaceutical Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 52. Haisco Pharmaceutical Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 53. Easton Biopharmaceuticals Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 54. Baiji Dichang Pharmaceutical Revenue Growth Rate in Long-acting DPP-4 Inhibitor Drug Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions